Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)
China
· Delayed Price · Currency is CNY 15.00
+0.09 (0.60%)
Nov 19, 2024, 3:00 PM CST
Tasly Pharmaceutical Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 22,469 | 25,427 | 15,988 | 23,778 | 22,302 | 23,252 | Upgrade
|
| Market Cap Growth | 11.23% | 59.04% | -32.76% | 6.62% | -4.09% | -19.94% | Upgrade
|
| Enterprise Value | 19,982 | 24,806 | 15,103 | 23,396 | 23,975 | 30,193 | Upgrade
|
| Last Close Price | 15.04 | 16.35 | 10.11 | 14.43 | 13.14 | 13.40 | Upgrade
|
| PE Ratio | 25.60 | 22.80 | - | 9.19 | 17.52 | 20.30 | Upgrade
|
| Forward PE | 15.04 | 7.46 | 4.03 | 8.30 | 12.53 | 13.62 | Upgrade
|
| PS Ratio | 2.63 | 2.93 | 1.85 | 2.99 | 1.64 | 1.22 | Upgrade
|
| PB Ratio | 1.77 | 2.00 | 1.26 | 1.79 | 1.80 | 1.96 | Upgrade
|
| P/TBV Ratio | 1.99 | 2.16 | 1.34 | 1.93 | 1.92 | 2.20 | Upgrade
|
| P/FCF Ratio | 11.05 | 13.33 | 8.53 | 10.67 | 16.13 | 24.49 | Upgrade
|
| P/OCF Ratio | 9.02 | 9.87 | 7.01 | 8.49 | 12.45 | 13.84 | Upgrade
|
| PEG Ratio | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | Upgrade
|
| EV/Sales Ratio | 2.33 | 2.86 | 1.75 | 2.94 | 1.77 | 1.59 | Upgrade
|
| EV/EBITDA Ratio | 10.86 | 13.39 | 8.51 | 14.20 | 12.44 | 13.51 | Upgrade
|
| EV/EBIT Ratio | 14.66 | 17.23 | 11.27 | 18.83 | 17.28 | 16.34 | Upgrade
|
| EV/FCF Ratio | 9.83 | 13.01 | 8.05 | 10.49 | 17.34 | 31.80 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.22 | 0.17 | 0.13 | 0.23 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 1.18 | 1.46 | 1.17 | 0.98 | 1.45 | 3.65 | Upgrade
|
| Debt / FCF Ratio | 1.07 | 1.48 | 1.16 | 0.76 | 2.02 | 8.59 | Upgrade
|
| Asset Turnover | 0.50 | 0.52 | 0.52 | 0.48 | 0.67 | 0.77 | Upgrade
|
| Inventory Turnover | 1.66 | 1.76 | 2.04 | 1.85 | 4.16 | 5.28 | Upgrade
|
| Quick Ratio | 2.16 | 2.91 | 3.54 | 4.09 | 2.73 | 1.54 | Upgrade
|
| Current Ratio | 2.70 | 3.69 | 4.31 | 4.99 | 3.26 | 1.91 | Upgrade
|
| Return on Equity (ROE) | 6.56% | 8.02% | -2.68% | 18.74% | 8.99% | 8.70% | Upgrade
|
| Return on Assets (ROA) | 4.94% | 5.42% | 5.08% | 4.70% | 4.28% | 4.70% | Upgrade
|
| Return on Capital (ROIC) | 5.44% | 5.92% | 5.61% | 5.14% | 4.93% | 5.66% | Upgrade
|
| Earnings Yield | 3.91% | 4.21% | -1.65% | 9.92% | 5.05% | 4.31% | Upgrade
|
| FCF Yield | 9.05% | 7.50% | 11.73% | 9.38% | 6.20% | 4.08% | Upgrade
|
| Dividend Yield | 3.43% | 2.02% | 3.26% | 2.29% | 2.51% | 2.46% | Upgrade
|
| Payout Ratio | 62.05% | 52.58% | - | 25.88% | 70.99% | 90.23% | Upgrade
|
| Buyback Yield / Dilution | -2.18% | -1.77% | 2.29% | -0.08% | 1.06% | -0.16% | Upgrade
|
| Total Shareholder Return | 1.25% | 0.25% | 5.56% | 2.20% | 3.57% | 2.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.